(PharmaNewsWire.Com, April 17, 2017 ) As per the syndicated report published by Market Data Forecast Europe Cervical Cancer Diagnostics and Therapeutics Market which is estimated to be USD 955.80 million in 2016 is poised to reach USD 1129.72 million by 2021, at a CAGR of 3.40% from 2016 to 2021. It can be attributed to the factors such as increase of pipeline cervical cancer screening tests as well as because of supportive government initiatives for both prevention and treatment of cancer. However certain challenges like high treatment cost and uncertain reimbursement policies must be dealt with to attain the full potential.
Cervical cancers and cervical pre-cancers are categorized by their respective looks under a microscope. The major types of cervical cancers include squamous cell carcinoma and adenocarcinoma. Cases of Cervical pre-cancers have been diagnosed far more often than invasive cervical cancer in recent years.
Europe Cervical Cancer Diagnostics and Therapeutics Market is segmented based on Diagnostic test, methods, therapies and end-users as mentioned below for attaining a more granular perspective of the market. In the report, each sub segment is provided with Market Size Estimations and Y-o-Y Forecasts.
Based on Diagnostic test: Pap smear test HPV testing Colposcopy Cervical cancer biopsy
Based on Methods: Molecular method Cytopathological method Physical method
Based on Therapies: Surgery Radiation Therapy Chemotherapy Other Therapies
Based on End-Users: Hospitals Laboratories Independent physicians Clinics Other end-users
Europe is an amalgamation of major economies like Germany, Spain, Italy, U.K. and France among others to name a few. The report justifies this by offering country wise data for the EU5 countries while taking some other predominant economies into consideration as well (Rest of Europe). As per the study France is poised to hold the major market share while Germany is the fastest growing market in this region.
Abbott Diagnostics, Alere, Beckman Coulter, Clinical Genomics, Companion Dx, EDP Biotech, Epigenomics AG, Exact Sciences, Fujirebio, Genomic Tree, Metabiomics, Oncocyte (Biotime), Quest Diagnostics, Randox Laboratories, Siemens Healthcare, Volition Rx are the major players operating in the Europe Cervical Cancer Diagnostics and Therapeutics Market. According to recent reports, Abbott are set to buy Alere for a deal of USD 4.4 billion, in an attempt to strengthen its hold in the healthcare market.
The Cervical Cancer Diagnostics and Therapeutics market study offers the following deliverables:
Regional and country-level analysis that provides an innate perspective of European region and the aforementioned countries
Meticulously identifying the key areas of market growth by providing market size forecasts and y-o-y estimations at a Segment-level analysis
Explanations of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
Study of macro and micro environmental factors that affect the European market presented in the form of PESTLE and Porters Five Forces Analyses
Company overview, product portfolios, key financial information (subjected to availability), SWOT analysis and analyst overview of the key market players operating in the region
Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
Expertly devised Market Outlook - Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
Checkout other related studies in the Diagnostics Segment:
About Market Data Forecast: The publisher of this report Market Data Forecast is well known for the services they render in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. Their research reports section offers a wide variety of market studies ranging from all-encompassing comprehensive market studies to product specific niche markets covering Europe among other regions of the global market as well, that too with competitive pricing options. For more info kindly visit, www.marketdataforecast.com
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
